Effect of Sphingomyelinase-Treated LDLs on HUVECs
Molecules · 2023
DOI: 10.3390/molecules28052100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Angelica Giuliani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy. Hauptthemen laut MEDLINE: Sphingomyelin Phosphodiesterase, Atherosclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondi Ateneo-UNIVPM.
Abstract (Originalsprache)
Low-density lipoproteins (LDLs) exert a key role in the transport of esterified cholesterol to tissues. Among the atherogenic modifications of LDLs, the oxidative modification has been mainly investigated as a major risk factor for accelerating atherogenesis. Since LDL sphingolipids are also emerging as important regulators of the atherogenic process, increasing attention is devoted to the effects of sphingomyelinase (SMase) on LDL structural and atherogenic properties. The aims of the study were to investigate the effect of SMase treatment on the physical-chemical properties of LDLs. Moreover, we evaluated cell viability, apoptosis, and oxidative and inflammatory status in human umbilical vein endothelial cells (HUVECs) treated with either ox-LDLs or SMase-treated LDLs (SMase-LDLs). Both treatments were associated with the accrual of the intracellular ROS and upregulation of the antioxidant Paraoxonase 2 (PON2), while only SMase-LDLs induced an increase of superoxide dismutase 2 (SOD2), suggesting the activation of a feedback loop to restrain the detrimental effects of ROS. The increased caspase-3 activity and reduced viability observed in cells treated with SMase-LDLs and ox-LDLs suggest a pro-apoptotic effect of these modified lipoproteins on endothelial cells. Moreover, a strong proinflammatory effect of SMase-LDLs compared to ox-LDLs was confirmed by an increased activation of NF-κB and consequent increased expression of its downstream cytokines IL-8 and IL-6 in HUVECs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy.
- Department of Life and Environmental Science, Polytechnic University of Marche, 60100 Ancona, Italy.
- Department of Clinical Science, Polytechnic University of Marche, 60100 Ancona, Italy.
- Clinic of Laboratory and Precision Medicine, IRCCS INRCA, 60121 Ancona, Italy.
- Laboratory Medicine Unit, Azienda Ospedaliero Universitaria delle Marche, 60126 Ancona, Italy.
ORCID-Profile: Deborah Ramini, Jacopo Sabbatinelli, Fabiola Olivieri, Tiziana Bacchetti
Förderung
- Fondi Ateneo-UNIVPM
Zitieren
APA
Giuliani, A., Morresi, C., Mazzuferi, G., Bellachioma, L., Ramini, D., Sabbatinelli, J., Olivieri, F., Bacchetti, T., & Ferretti, G. (2023). Effect of Sphingomyelinase-Treated LDLs on HUVECs. Molecules. https://doi.org/10.3390/molecules28052100
Vancouver
Giuliani A, Morresi C, Mazzuferi G, Bellachioma L, Ramini D, Sabbatinelli J, et al. Effect of Sphingomyelinase-Treated LDLs on HUVECs. Molecules. 2023. doi:10.3390/molecules28052100
BibTeX
@article{Giuliani2023,
author = {Giuliani, Angelica and Morresi, Camilla and Mazzuferi, Gabriele and Bellachioma, Luisa and Ramini, Deborah and Sabbatinelli, Jacopo and Olivieri, Fabiola and Bacchetti, Tiziana and Ferretti, Gianna},
title = {Effect of Sphingomyelinase-Treated LDLs on HUVECs},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28052100}
}
EUVIMED